Vycor Medical, Inc.
VYCO
$0.068
$0.00324.94%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -107.84% | -18.97% | 66.85% | 82.79% | 80.42% |
| Total Depreciation and Amortization | 1.80% | 0.49% | -0.33% | -0.98% | -4.54% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 31.48% | -82.48% | -89.43% | -94.54% | -95.80% |
| Change in Net Operating Assets | 1,756.30% | 506.85% | 1,100.00% | 137.40% | 495.00% |
| Cash from Operations | 1,193.68% | 210.10% | 105.90% | 113.55% | 93.75% |
| Capital Expenditure | -221.88% | -2,450.00% | -235.71% | -235.71% | -14.29% |
| Sale of Property, Plant, and Equipment | -100.00% | -66.67% | 66.67% | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -229.03% | -1,020.00% | -256.00% | -232.14% | -10.71% |
| Total Debt Issued | -31.90% | -23.85% | -21.84% | -49.17% | 42.78% |
| Total Debt Repaid | -1.29% | -67.99% | -80.43% | -84.58% | -1,632.84% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -110.39% | -104.36% | -102.04% | -99.88% | -54.95% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 141.80% | 565.66% | 88.04% | 137.73% | 179.74% |
